May 30, 2026 Prostate Health Supplements From PureHealth Research Enhance Bladder Control With Clinical Lycopene
May 30, 2026 Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)